Submitting for consideration and confirmation to the Hawai'i Advisory Commission on Drug Abuse and Controlled Substances, Gubernatorial Nominee, EMILY ANDRADE, for a term to expire 06-30-2028.

2025 Regular Session

Bill GM 544 confirms Emily Andrade to the Hawai'i Advisory Commission on Drug Abuse, enhancing efforts to combat substance abuse and improve public health until 2028.

Confirmed. Ayes, 22. Aye(s) with reservations: none. Noes, 2 (Senator(s) Awa, DeCorte). Excused, 1 (Senator(s) Fevella).

#hawai'iadvisorycommissionondrugabuseandcontrolledsubstances

Bill Overview

Bill Number: GM 544
Title: Submitting for consideration and confirmation to the Hawai'i Advisory Commission on Drug Abuse and Controlled Substances, Gubernatorial Nominee, EMILY ANDRADE, for a term to expire 06-30-2028.
Status: Confirmed
Introduced: January 23, 2025
Classification: Proclamation
Subject: Hawai'i Advisory Commission on Drug Abuse and Controlled Substances

Purpose and Intent

Bill GM 544 is a gubernatorial nomination submitted by Governor Josh Green, M.D., to confirm Emily Andrade as a member of the Hawai'i Advisory Commission on Drug Abuse and Controlled Substances. The primary intent of this bill is to fill a position on the commission, which plays a crucial role in addressing issues related to drug abuse and controlled substances in Hawaii.

Key Provisions

Nominee: Emily Andrade is nominated for a term that will expire on June 30, 2028.

Commission Role: The Hawai'i Advisory Commission on Drug Abuse and Controlled Substances is responsible for advising the state on policies and programs related to drug abuse prevention, treatment, and control of substances.

Legislative Actions and Timeline

January 23, 2025: Bill GM 544 was introduced and referred to the Committee on Commerce and Consumer Protection (CPN).

March 4, 2025: The bill was re-referred to the Committee on Health and Human Services (HHS).

April 2, 2025: A public hearing was scheduled for April 7, 2025, at 1:00 PM.

April 7, 2025: The HHS committee recommended to "Advise and Consent" to the nomination, with a unanimous vote of 5 Ayes.

April 11, 2025: The bill was reported from HHS with a recommendation for confirmation.

April 14, 2025: The Senate confirmed the nomination with 22 Ayes, 2 Noes (Senators Awa and DeCorte), and 1 Excused (Senator Fevella).

Impact

The confirmation of Emily Andrade to the Hawai'i Advisory Commission on Drug Abuse and Controlled Substances is expected to contribute to the state's efforts in combating drug abuse and managing controlled substances. The commission's work is vital for developing effective policies and programs that address substance abuse issues in Hawaii, impacting public health and safety.

Conclusion

Bill GM 544 successfully confirmed Emily Andrade's nomination to the Hawai'i Advisory Commission on Drug Abuse and Controlled Substances, ensuring that the commission continues to have qualified members to guide its initiatives until June 30, 2028. This appointment reflects the state's commitment to addressing drug-related challenges through informed leadership and policy-making.

Bill